Skip to main content
logo
Plus Therapeutics, Inc. (PSTV)
NASDAQ: PSTV · Real-Time Price · USD
5.82
-0.61 (-9.49%)
At close: May 29, 2026, 4:00 PM EDT
5.84
+0.02 (0.34%)
After-hours: May 29, 2026, 7:46 PM EDT

Plus Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-11.93-22.39-12.98-13.32-20.28-13.32
Depreciation & Amortization
0.40.450.870.630.620.63
Stock-Based Compensation
-0.651.540.550.570.610.57
Other Adjustments
-12.535.67-2.220.380.480.38
Changes in Accounts Payable
-2.71-5.624.7-3.686.45-3.68
Changes in Other Operating Activities
-3.16-0.42-1.482.56-0.862.78
Operating Cash Flow
-20.84-20.78-10.55-12.85-12.97-12.85
Capital Expenditures
-0.88-0.07-0.15---0.16
Sale of Property, Plant & Equipment
-0.03----
Purchases of Intangible Assets
---0.55-0.16-0.76-
Purchases of Investments
-19.05-9.35-15.59---
Proceeds from Sale of Investments
3.228.5412.17---
Investing Cash Flow
-12.95-0.85-4.11-0.16-0.76-0.16
Long-Term Debt Issued
1.754.493.29---
Long-Term Debt Repaid
-1.1-7-4-1.61-1.61-1.61
Net Long-Term Debt Issued (Repaid)
0.65-2.51-0.7-1.61-1.61-1.61
Issuance of Common Stock
37.838.547.275.5315.835.53
Repurchase of Common Stock
---0.37-0.13--0.13
Net Common Stock Issued (Repurchased)
37.838.546.895.415.835.4
Other Financing Activities
-6.92-5.72--0.35-0.77-0.35
Financing Cash Flow
26.9430.316.193.4513.453.45
Net Cash Flow
-6.858.68-8.48-9.57-0.28-9.57
Free Cash Flow
-21.72-20.84-10.7-12.85-12.97-13.01
FCF Margin
-419.20%-399.81%-183.72%-261.57%-5791.07%-
Free Cash Flow Per Share
-3.37-6.70-34.74-102.29-185.28-403.60
Levered Free Cash Flow
-16.68-30.56-9.73-15.41-15.67-15.44
Unlevered Free Cash Flow
-25.24-20.96-10.75-13.81-13.5-12.86
SEC Filings: 10-K · 10-Q